Lose weight and keep it off?
Lose weight and keep it off? Yo-yo dieting. It's the bane of most dieters existence. You go to the gym and exercise, you reduce your caloric intake, you start to look pretty good! But sooner or later your body screams out "feed me, feed me"! What if there was a weight loss drug that could help you lose the weight and keep it off?
(PRWEB) May 16, 2001
May 14, 2001 -- Due to an illness in the family, the April and May editions of Obesity Meds And Research News (OMR) are being combined. Part 1 of our combined April/May issue is already on-line and available to OMR subscribers. The rest of our coverage will be on-line next week. Here's a sneak peek at just a few of the articles we have on tap!
Lose weight and keep it off?
Yo-yo dieting. It's the bane of most dieters existence. You go to the gym and exercise, you reduce your caloric intake, you start to look pretty good! But sooner or later your body screams out "feed me, feed me"! What if there was a weight loss drug that could help you lose the weight and keep it off? There may just be such a drug on the shelves in 3-5 years. This month OMR brings you the latest research on the drug Axokine, which reduces rebound overeating and weight gain in both humans and animals, even after the drug is discontinued. Is this too good to be true? How long does the effect last? How does the drug work? Find out this month.
Leptin, cannabinoids and food intake.
In March OMR presented the results of a study on an cannabinoid antagonist with positive human weight loss results. A recent study suggests, that endocannabinoids are regulated by leptin, making them another hormone in the leptin loop. This month, OMR discusses the research, the conclusions and how this new information fills in pieces of the "leptin puzzle".
These two stories are now on-line in part 1 of our April/May coverage!
Other late breaking drug development news.
Also this month. Find out more about:
Another drug that mimics the effects of leptin, but without leptin's negative effects on corticosterone levels, neuropeptide y and other appetite stimulating hormones.
The latest results on a cactus-derived anti-obesity drug now in human testing, which produced promising weight loss results in preclinical research.
A cholesterol metabolite from the dog fish shark with potent appetite suppressant and antidiabetic properties.
An on-line subscription to Obesity Meds And Research News gives you access to our entire database, including our recent review articles on cannabinoids and obesity and our 3 part series on the phentermine shortage. If you are interested in the subject of obesity from either a professional or patient viewpoint, OMR is indispensable. And subscribing is easy as the click of a mouse.
Obesity Meds And Research News is the largest and most reliable database on the web for information on obesity and weight loss. OMR has won numerous honors for excellence, including the Health A to Z and Health Links site awards. OMR articles appear in the Bariatrician the quarterly journal of the American Society of Bariatric Physicians. We are a top rated obesity site, ranking number one in Yahoo and
Excite and in the top 10 of virtually every major search engine. OMR is also linked to many hospitals, medical schools, research institutions and physician web sites.
Contact information: OBESITY MEDS AND RESEARCH NEWS, PO Box 19316, Alexandria, VA 22320-0316, telephone: 703/960-3649; fax: 703/960-7462; e-mail: subscriptions@obesity-news. com.
